Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets?

Nicola Silvestris; Oronzo Brunetti; Rosamaria Pinto; Daniela Petriella

首页> 外文期刊>Expert opinion on therapeutic targets >Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets?

【24h】

Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets?

机译：胰腺癌腺癌中的免疫突变签名：潜在治疗靶标的探索性研究？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Adenosquamous cancer of pancreas (ASCP) is a rare variant of pancreatic adenocarcinoma (PDAC).

机译：胰腺癌腺癌（ASCP）是胰腺炎腺癌（PDAC）的罕见变体。

著录项

来源
《Expert opinion on therapeutic targets》 |2018年第6期|共9页
作者
Nicola Silvestris; Oronzo Brunetti; Rosamaria Pinto; Daniela Petriella;
展开▼
作者单位

Medical Oncology Unit and Scientific Directorate Istituto Tumori “Giovanni Paolo II” Bari Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets? [J] . Nicola Silvestris, Oronzo Brunetti, Rosamaria Pinto, Expert opinion on therapeutic targets . 2018,第1a6期

机译：胰腺癌腺癌中的免疫突变签名：潜在治疗靶标的探索性研究？
2. Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden [J] . Jan Budczies, Anja Seidel, Petros Christopoulos, Oncoimmunology. . 2018,第12期

机译：综合分析癌症类型和跨癌症类型的免疫和遗传状态：突变签名超越肿瘤突变负担的影响
3. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets [J] . Schulze Kornelius, Imbeaud Sandrine, Letouze Eric, Nature Genetics . 2015,第5期

机译：肝细胞癌的外显子组测序确定新的突变特征和潜在的治疗靶标
4. Cancer Mutational Signatures Identification with Sparse Dictionary Learning [C] . Veronica Tozzo, Annalisa Barla International Meeting on Computational Intelligence Methods for Bioinformatics and Biostatistics . 2019

机译：癌症突变签名用稀疏的字典学习识别
5. Mechanisms and Therapeutic Targeting of NT5C2 Mutations in Relapsed Acute Lymphoblastic Leukemia [D] . Chelsea Dieck. 2019

机译：复发性急性淋巴细胞白血病中NT5C2突变的机制和治疗靶点
6. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms [O] . Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, 2019

机译：基于乳腺癌分子标记的治疗靶标的最新进展：遗传突变及其对当前治疗范例的启示
7. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. [O] . Schulze, Kornelius, Imbeaud, Sandrine, Letouzé, Eric, 2015

机译：肝细胞癌的外显子组测序确定了新的突变特征和潜在的治疗靶标。

Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets?

摘要

著录项

相似文献

相关主题

期刊订阅